{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:41:19Z","timestamp":1764603679195,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Allergic rhinitis (AR) and adenoidal hypertrophy (AH) are the most frequent causative disorders of nasal obstruction in children, leading to recurrent respiratory infections. Both nasal cavities are colonized by a stable microbial community susceptible to environmental changes and <jats:italic>Staphylococcus aureus<\/jats:italic> seems to play the major role. Furthermore, nasal microbiota holds a large number and variety of viruses with upper respiratory tract infections. This local microbiota deserves attention because its modification could induce a virtuous cross-talking with the immune system, with a better clearance of pathogens. Although AR and AH present a different etiopathogenesis, they have in common a minimal chronic inflammation surrounding nasal obstruction; hence it would be challenging to evaluate the effect of an immunomodulator on this minimal chronic inflammation with possible clinical and microbiological effects. The aim of this study is therefore to evaluate the efficacy of an immunomoldulator (Pidotimod) on nasal obstruction in children with AR and\/or AH and whether its action involves a variation of nasal microbiota.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We enrolled 76 children: those with allergic rhinitis (AR) sensitized to dust mites entered the AR group, those with adenoidal hypertrophy (AH) the AH group, those with both conditions the AR\/AH group and those without AR\u2009\u00b1\u2009AH as controls (CTRL). At the first visit they performed: skin prick tests, nasal fiberoptic endoscopy, anterior rhinomanometry, nasal swabs. Children with.<\/jats:p>\n<jats:p>AR\u2009\u00b1\u2009AH started treatment with Pidotimod.<\/jats:p>\n<jats:p>After 1 month they were re-evaluated performing the same procedures.<\/jats:p>\n<jats:p>The primary outcome was the evaluation of nasal obstruction after treatment and the secondary outcome was the improvement of symptoms and the changes in nasal microflora.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>All patients improved their mean nasal flow (mNF) in respect to the baseline. In AR children mNF reached that one of CTRL. In AH children\u00b1AR the mNF was lower in respect to CTRL and AR group. We did not find any differences among all the groups at the two different time points in nasal microflora.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Pidotimod is able to give an improvement in nasal obstruction, especially in AR children but this effect seems to be not mediated by changes in nasal microbiota.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13052-020-00859-8","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:02:58Z","timestamp":1594123378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-6082","authenticated-orcid":false,"given":"Giulia","family":"Brindisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Zicari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Marazzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Duse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"issue":"2","key":"859_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11882-019-0843-9","volume":"19","author":"F Mari\u00f1o-S\u00e1nchez","year":"2019","unstructured":"Mari\u00f1o-S\u00e1nchez F, Valls-Mateus M, de Los SG, Plaza AM, Cobeta I, Mullol J. Multimorbidities of Pediatric Allergic Rhinitis. Curr Allergy Asthma Rep. 2019;19(2):13.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"51","key":"859_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013783","volume":"97","author":"Y Cao","year":"2018","unstructured":"Cao Y, Wu S, Zhang L, Cao S, Li Q. Association of allergic rhinitis with obstructive sleep apnea: a meta-analysis. Medicine (Baltimore). 2018;97(51):e13783.","journal-title":"Medicine (Baltimore)"},{"key":"859_CR3","doi-asserted-by":"publisher","unstructured":"Hoyte FCL, Nelson HS. Recent advances in allergic rhinitis. F1000Res. 2018;7:F1000 Faculty Rev-1333. Published 2018 Aug 23. https:\/\/doi.org\/10.12688\/f1000research.15367.1.","DOI":"10.12688\/f1000research.15367.1"},{"issue":"5","key":"859_CR4","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jaci.2018.01.025","volume":"141","author":"LE Van der Vlugt","year":"2018","unstructured":"Van der Vlugt LE, Eger K, M\u00fcller C, et al. Farm dust reduces viral load in human bronchial epithelial cells by increasing barrier function and antiviral responses. J Allergy Clin Immunol. 2018 May;141(5):1949\u201352.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"859_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1185\/03007995.2015.1027182","volume":"31","author":"F Occasi","year":"2015","unstructured":"Occasi F, De Castro G, Zicari AM, Indinnimeo L, Tancredi G, Duse M. Sublingual immunotherapy in children and its potential beneficial collateral effect on respiratory tract infections. Curr Med Res Opin. 2015 May;31(5):939\u201341.","journal-title":"Curr Med Res Opin"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2500\/ajra.2015.29.4126","volume":"29","author":"RM Rezende","year":"2015","unstructured":"Rezende RM, Amato FS, Barbosa AP, et al. Does atopy influence the effectiveness of treatment of adenoid hypertrophy with mometasone furoate? Am J Rhinol Allergy. 2015;29:54\u20136.","journal-title":"Am J Rhinol Allergy"},{"key":"859_CR7","doi-asserted-by":"crossref","unstructured":"Mahdavinia M. The nasal microbiome: opening new clinical research avenues for allergic disease. Expert Rev Clin Immunol. 2018 Aug;14(8):645\u20137.","DOI":"10.1080\/1744666X.2018.1500177"},{"issue":"5","key":"859_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1400216","volume":"1","author":"CM Liu","year":"2015","unstructured":"Liu CM, Price LB, Hungate BA, et al. Staphylococcus aureus and the ecology of the nasal microbiome. Sci Adv. 2015 Jun 5;1(5):e1400216.","journal-title":"Sci Adv"},{"issue":"1","key":"859_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12948-015-0012-1","volume":"13","author":"B Ferrario","year":"2015","unstructured":"Ferrario B, Garuti S, Braido F, Canonica GW. Pidotimod state of art. Clin Mol Allergy. 2015;13(1):8.","journal-title":"Clin Mol Allergy"},{"issue":"4","key":"859_CR10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","volume":"140","author":"JL Brozek","year":"2017","unstructured":"Brozek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.ijporl.2003.07.018","volume":"67","author":"P Cassano","year":"2003","unstructured":"Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendescopic findings: a novel approch to therapeutic management. Int J Pediatr Otolaryngol. 2003;67:1303\u20139.","journal-title":"Int J Pediatr Otolaryngol"},{"issue":"5","key":"859_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/all.12120","volume":"68","author":"V van Kampen","year":"2013","unstructured":"van Kampen V, de Blay F, Folletti I, et al. EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies. Allergy. 2013;68(5):580\u20134.","journal-title":"Allergy"},{"key":"859_CR13","first-page":"151","volume":"22","author":"C Pa","year":"1984","unstructured":"Pa C. Committee report on standardization of rhinomanometry. Rhinology. 1984;22:151\u20135.","journal-title":"Rhinology"},{"issue":"3","key":"859_CR14","doi-asserted-by":"publisher","first-page":"174180","DOI":"10.1002\/ppul.10066","volume":"33","author":"A Zapletal","year":"2002","unstructured":"Zapletal A, Chalupov\u00e1 J. Nasal airflow and resistance measured by active anterior rhinomanometry in healthy children and adolescents. Pediatr Pulmonol. 2002;33(3):174180.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"859_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014 Feb;43(2):343\u201373.","journal-title":"Eur Respir J"},{"issue":"10","key":"859_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/ppul.20908","volume":"43","author":"JS Loeb","year":"2008","unstructured":"Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD. Acceptability and epeatability of spirometry in children using updated ATS\/ERS criteria. Pediatr Pulmonol. 2008 Oct;43(10):1020\u20134.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"859_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1185\/03007995.2015.1009532","volume":"31","author":"AM Zicari","year":"2015","unstructured":"Zicari AM, Occasi F, Montanari G, et al. Intranasal budesonide in children affected by persistent allergic rhinitis and its effect on nasal patency and nasal obstruction symptom evaluation (NOSE) score. Curr Med Res Opin. 2015 Mar;31(3):391\u20136.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"859_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00405-013-2492-2","volume":"271","author":"C \u00c7evik","year":"2014","unstructured":"\u00c7evik C, Yula E, Yengil E, G\u00fclmez M\u0130, Akbay E. Identification of nasal bacterial flora profile and carriage rates of methicillin-resistant Staphylococcus aureus in patients with allergic rhinitis. Eur Arch Otorhinolaryngol. 2014 Jan;271(1):103\u20137.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"859_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaci.2018.01.033","volume":"142","author":"M Mahdavinia","year":"2018","unstructured":"Mahdavinia M, Engen PA, Lo Savio PS, et al. The nasal microbiome in patients with chronic rhinosinusitis: analyzing the effects of atopy and bacterial functional pathways in 111 patients. J Allergy Clin Immunol. 2018;142(1):287\u201390.","journal-title":"J Allergy Clin Immunol"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2500\/ajra.2014.28.4050","volume":"28","author":"CH Choi","year":"2014","unstructured":"Choi CH, Poroyko V, Watanabe S, et al. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014;28:281\u20136.","journal-title":"Am J Rhinol Allergy"},{"issue":"6","key":"859_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/alr.21934","volume":"7","author":"D Lal","year":"2017","unstructured":"Lal D, Keim P, Delisle J, et al. Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects. Int Forum Allergy Rhinol. 2017 Jun;7(6):561\u20139.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"859_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","volume":"17","author":"SM Teo","year":"2015","unstructured":"Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704\u201315.","journal-title":"Cell Host Microbe"},{"issue":"10","key":"859_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046803","volume":"7","author":"PA Cardenas","year":"2012","unstructured":"Cardenas PA, Cooper PJ, Cox MJ, et al. Upper airways microbiota in antibiotic-naive wheezing and healthy infants from the tropics of rural Ecuador. PLoS One. 2012;7(10):e46803.","journal-title":"PLoS One"},{"key":"859_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1824-7288-39-75","volume":"39","author":"GV Zuccotti","year":"2013","unstructured":"Zuccotti GV, Mameli G. Pidotimod: the past and the present. Ital J Pediatr. 2013;39:75.","journal-title":"Ital J Pediatr"},{"key":"859_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phrs.2015.04.007","volume":"97","author":"C Mameli","year":"2015","unstructured":"Mameli C, Pasinato A, Picca M, et al. Pidotimod for the prevention of acute respiratory infections inhealthy children entering into daycare: a double blind randomizedplacebo controlled study. Pharmacol Res. 2015;97:79\u201383.","journal-title":"Pharmacol Res"},{"issue":"1","key":"859_CR26","first-page":"253","volume":"27","author":"GV Zuccotti","year":"2013","unstructured":"Zuccotti GV, Mameli C, Trabattoni D, et al. Immunomodulating activity of Pidotimod in children with Down syndrome. J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):253\u20138.","journal-title":"J Biol Regul Homeost Agents"},{"key":"859_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1824-7288-39-29","volume":"39","author":"S Carta","year":"2013","unstructured":"Carta S, Silvestri M, Rossi GA. Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression. Ital J Pediatr. 2013 May 10;39:29.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"859_CR28","first-page":"753","volume":"28","author":"M Fogli","year":"2014","unstructured":"Fogli M, Caccuri F, Iaria ML, et al. The immunomodulatory molecule Pidotimod induces the expression of the NOD-like receptor NLRP12 and attenuates TLR-induced inflammation. J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):753\u201366.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"12","key":"859_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.intimp.2009.08.010","volume":"9","author":"C Giagulli","year":"2009","unstructured":"Giagulli C, Noerder M, Avolio M, et al. Pidotimod promotes functional maturation of dendritic cells and display adjuvant properties at the nasal mucosa level. Int Immunopharmacol. 2009;9(12):1366\u201373.","journal-title":"Int Immunopharmacol"},{"key":"859_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12967-015-0649-z","volume":"13","author":"S Esposito","year":"2015","unstructured":"Esposito S, Garziano M, Rainone V, et al. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community acquired pneumonia. J Transl Med. 2015 Sep 3;13:288.","journal-title":"J Transl Med"},{"issue":"3","key":"859_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1081\/JAS-120026085","volume":"41","author":"D Gourgiotis","year":"2004","unstructured":"Gourgiotis D, Papadopoulos NG, Bossios A, Zamanis P, Saxoni-Papageorgiou P. Immune modulator Pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children. J Asthma. 2004;41(3):285\u20137.","journal-title":"J Asthma"},{"issue":"2","key":"859_CR32","first-page":"151","volume":"32","author":"F Zhai","year":"2011","unstructured":"Zhai F, Liu X. The effect of Pidotimod in the prevention and treatment of pediatric bronchial asthma. Chin J Biochem Pharm. 2011;32(2):151\u20135.","journal-title":"Chin J Biochem Pharm"},{"issue":"2","key":"859_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4193\/Rhin15.120","volume":"54","author":"F Occasi","year":"2016","unstructured":"Occasi F, Duse M, Vittori T, et al. Primary school children often underestimate their nasal obstruction. Rhinology. 2016 Jun;54(2):164\u20139.","journal-title":"Rhinology."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-020-00859-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T23:23:14Z","timestamp":1625613794000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-00859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-00859-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Comitee of \u201cSapienza\u201d University of Rome. The procedures were in accordance with the ethical standards of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}